Literature DB >> 7334186

Steroid hormone receptors and sex chromatin frequency in breast cancer.

M Smethurst, N P Bishun, D Fernandez, J Allen, J I Burn, J Alaghband-Zadeh, D C Williams.   

Abstract

Cytosol and nuclear estrogen receptors and cytosol progesterone receptors were measured in 17 primary breast tumors and compared with sex chromatin frequencies. In cases with sex chromatin frequencies of greater than 20% there were 7/7 tumors with cytosol estrogen and progesterone receptors, 6/7 with cytosol and nuclear estrogen receptors, and 6/7 with all 3 receptors. This high proportion of receptor positive cases was not observed at lower sex chromatin frequencies. Sex chromatin frequencies in all the cytosol estrogen and progesterone receptor positive tumors were significantly higher (p less than 0.05) than in the other groups. Our results suggest a possible association between the presence of steroid hormone receptors and sex chromatin frequencies of greater than 20%.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7334186     DOI: 10.1007/BF03348311

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  10 in total

1.  Clinical-cytological correlations of mammary carcinoma based upon sex-chromatin counts; a preliminary study.

Authors:  V M KIMEL
Journal:  Cancer       Date:  1957 Sep-Oct       Impact factor: 6.860

2.  The relationship between Barr bodies and cytoplasmic oestradiol receptors in human breast cancer.

Authors:  N P Bishun; M Smethurst; D C Williams
Journal:  Clin Oncol       Date:  1979-06

3.  Comparison of soluble oestrogen and progestin receptor content of primary breast tumours from Japan and Britain.

Authors:  R J King; J L Hayward; S Kumaoka; H Yamamoto
Journal:  Eur J Cancer       Date:  1977-09       Impact factor: 9.162

4.  Barr body distribution and estrogen receptor protein in mammary carcinoma.

Authors:  P P Rosen; A Savino; C Menendez-Botet; J A Urban; V Mike; M K Schwartz; M R Melamed
Journal:  Ann Clin Lab Sci       Date:  1977 Nov-Dec       Impact factor: 1.256

5.  An improved assay for nuclear estrogen receptor in experimental and human breast cancer.

Authors:  R E Garola; W L McGuire
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

6.  Evaluation of breast tumour sex chromatin (Barr body) as an index of survival and response to pituitary ablation.

Authors:  M Perry
Journal:  Br J Surg       Date:  1972-09       Impact factor: 6.939

7.  Barr body frequency in the human breast cancer tissue. A prospective study on its prognostic value and its correlation with specific oestradiol receptors.

Authors:  S Rajeswari; S N Ghosh; P N Shah; V J Borah
Journal:  Eur J Cancer       Date:  1977-02       Impact factor: 9.162

Review 8.  Current status of estrogen and progesterone receptors in breast cancer.

Authors:  W L McGuire; K B Horwitz; O H Pearson; A Segaloff
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

9.  Triple sex chromatin, and other sex chromatin anomalies, in tumours of females.

Authors:  N B Atkin
Journal:  Br J Cancer       Date:  1967-03       Impact factor: 7.640

10.  Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer?

Authors:  D M Barnes; L G Skinner; G G Ribeiro
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

  10 in total
  4 in total

1.  Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer.

Authors:  W Remmele; U Hildebrand; H A Hienz; P J Klein; M Vierbuchen; L J Behnken; B Heicke; E Scheidt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 2.  Satellite DNAs and human sex chromosome variation.

Authors:  Monika Cechova; Karen H Miga
Journal:  Semin Cell Dev Biol       Date:  2022-05-27       Impact factor: 7.499

3.  The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer.

Authors:  Ronan Chaligné; Tatiana Popova; Marco-Antonio Mendoza-Parra; Mohamed-Ashick M Saleem; David Gentien; Kristen Ban; Tristan Piolot; Olivier Leroy; Odette Mariani; Hinrich Gronemeyer; Anne Vincent-Salomon; Marc-Henri Stern; Edith Heard
Journal:  Genome Res       Date:  2015-02-04       Impact factor: 9.043

4.  Sex determination efficacy of Papanicolaou and acriflavine Schiff stains in buccal smears.

Authors:  Tibin Kaithappillil Baby; Priya Thomas; Jayanthi Palani; Rekha Krishna Pillai; Bindhu Pushparajan Ramakrishnan
Journal:  J Forensic Dent Sci       Date:  2017 Jan-Apr
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.